Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This document notes an ongoing Phase 1 study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of BMS-986489 in Chinese participan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• BMS-986489

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Small Cell Lung Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING